Rejuvenate Bio CEO highlights ambitious approach of using gene therapy to reverse aging
CEO and Co-founder Daniel Oliver share how he and his co-founder started the company and their vision for treating age-related conditions.
Biotech falls short on diversity in workplace, exec teams, according to report
BIO's first annual report on diversity in the workplace found room for improvement, as biotech workforces - especially at the executive level - were found to not represent the U.S. population. The report was based on a survey of nearly 100 companies in late spring 2019.
Changes in Nurse Staffing Answer Clinician Demands
The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.
A decade after biosimilars pathway’s creation, FDA issues final interchangeability rules
The rules are still more restrictive than the European Medicines Agency's, which allow national governments to determine interchangeability. The FDA would require additional testing to demonstrate products can be freely substituted like generic pharmaceuticals.
MedCity News launches biopharma-focused newsletter
The biotech century has arrived, and it's consequently now more important than ever for us to highlight our coverage of biopharma.
Biopharma startup financing had strong showing in 2018, report shows
The report, by PitchBook, shows figures consistent with a similar report earlier this month by Silicon Valley Bank, which forecast more M&A deals this year.
Bristol-Myers Squibb to acquire Celgene in $74B deal
The acquisition brings together two of the largest drugmakers in the country, both of which are major players in biopharma, particularly oncology.
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
Blockchain becomes a ‘source of truth’ for biopharma
Although blockchain faces regulatory hurdles and skepticism, its potential as a shared, yet secure ledger system to improve the pharmaceutical supply chain integrity and clinical trials is making it attractive for experimentation and investment by drugmakers.
TraceLink raises $93 million in Series D financing round
The company's life sciences track-and-trace network reaches drugmakers, pharmacies and others, with a customer base of more than 930 companies.
Precision medicine will increase drug prices and that’s a good thing
Precision medicine may also lead to more novel reimbursement structures, such as indication-specific pricing and performance-based pricing.
How will millennials shape the future of the biotech industry?
In many ways, the biotech field is the healthcare equivalent to the Millennial generation.
Tackling Rising Drug Costs and Growing Popularity of GLP-1’s
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.
How Biotech Is Revolutionizing Personalized Medicine
In 2005, my late father gave a lecture at Stanford University discussing personalized nutrition for cancer patients. He talked about nutrients that could be absorbed by both normal cells and cancer cells and would be customized to each patient’s unique status. Since then, personalized medicine has rapidly advanced and is becoming an increasingly larger market […]
3 Biotech Trends That Will Change the World
I don’t know about you, but sometimes I think the latest biotechnology developments were ripped from the pages of a science fiction novel. Gene editing cures a little girl’s leukemia; an Italian doctor plans to perform the first human head transplant in 2017; and the U.S. Food and Drug Administration recently approved the first commercial […]
Morning Read: Illumina partners with investors to launch digital hub for genomics
Illumina has partnered with Warburg Pincus and Sutter Hill Ventures to create digital hub Helix for consumers to obtain genetic tests and complementary services from third parties.
As more tech companies enter healthcare, developing clinical trial software poses as many risks as rewards
Taking on clinical trials adds another dimension to the healthIT challenge.
U.S. House overwhelmingly passes 21st Century Cures Act
The bipartisan 21st Century Cures Act is meant to streamline regulatory approval of devices and drugs through the Food and Drug Administration, as well as provide additional research funding for the National Institutes of Health.